STOCK TITAN

Invivyd to Participate at the 8th Annual Evercore Healthcare Conference

Invivyd (Nasdaq: IVVD) announced that company management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 2:35 p.m. ET in Miami, FL.

(Neutral)
(Neutral)
Tags

Invivyd (Nasdaq: IVVD) announced that company management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 2:35 p.m. ET in Miami, FL.

A live webcast will be available in the investor section of the company website at investors.invivyd.com, and the presentation will be archived for approximately 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Nov 25 session
-5.42% close to close Open Argus
Details

News Market Reaction – IVVD

On Nov 25, the day this news came out, IVVD closed 5.42% below the previous close.

Data tracked by StockTitan Argus for the Nov 25 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW HAVEN, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 2:35 p.m. ET in Miami, FL.

A live webcast of the fireside chat will be available in the investor section of the company's website at investors.invivyd.com and will be archived for approximately 90 days following the presentation.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:

Media Relations
(781) 208-0160
media@invivyd.com

Investor Relations
(781) 208-1747
investors@invivyd.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Invivyd (IVVD) present at the Evercore Healthcare Conference?

Invivyd management will present on December 2, 2025 at 2:35 p.m. ET in Miami.

How can investors watch Invivyd's (IVVD) fireside chat on December 2, 2025?

A live webcast will be available in the investor section at investors.invivyd.com.

How long will Invivyd's (IVVD) Evercore webcast be available after the presentation?

The webcast will be archived on the company site for approximately 90 days following the presentation.

What is the location and event for Invivyd's (IVVD) December 2, 2025 presentation?

The presentation is part of the 8th Annual Evercore Healthcare Conference in Miami, FL.

Will Invivyd (IVVD) provide a transcript or replay of the fireside chat?

A live webcast and archived replay will be available on the investor website for about 90 days.

Where on Invivyd's site can shareholders find the Evercore Conference webcast?

Go to the Investors section at investors.invivyd.com to access the live webcast and archive.

Keep reading